Skip to content
Advanced Technology International
  • Who We Serve
    • Government Agencies
    • Innovators
  • R&D Opportunities
    • Active & Upcoming Opportunities
    • Project Awards
  • Join a Collaboration
    • Search Tool
    • Portfolio
  • OTA
  • About
    • Who We Are
    • Leadership
    • TechConnect
    • ATI Foundation
    • Corporate Impact
    • Contact Us
  • News & Events
    • News
    • Events
  • Careers
  • Ischemix, Inc. receives US Department of Defense funding of $2.9 million to conduct Phase 1 study of CMX-2043, a novel compound for the treatment of acute TBI

    0 words0 min read

    This competitive award was granted by US Army Medical Research and Development Command (USAMRDC), Combat Casualty Care Research Program (CCCRP) in collaboration with the Medical Technology Enterprise Consortium (MTEC), a 501(c)(3) biomedical technology consortium.

    Read More
Previous363738Next

About Us

  • Leadership
  • ATI Foundation
  • Careers
  • News

Who We Serve

  • Government Agencies
  • Innovators

Get Engaged

  • Active and Upcoming R&D Opportunities
  • Portfolio
  • Doing Business with ATI
  • CMMC Resources
  • ATI & Collaboration Events

CONTACT US

315 Sigma Drive
Summerville, SC 29486
Email: info@ati.org

Advanced Technology International

© Copyright 2012 - 2026 | Advanced Technology International

ATI

Privacy & Terms of Use | Accessibility | Site Map

Page load link
Go to Top